Position in ZTS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$31,992,590
-$2,519,710 QoQ
Shares Held
270,642
-1.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CIBC Asset Management Inc holds $45,054,973 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (71.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
270,642 | $31,992,590 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
148,384 | $4,469,326 | |
| 3 | VTRS |
Viatris Inc
|
257,647 | $3,480,810 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
2,465 | $1,461,695 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
250,795 | $1,354,293 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
5,544 | $730,366 | |
| 7 | HLN |
Haleon plc
|
53,465 | $535,184 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
15,695 | $375,581 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,992,590 | 270,642 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $34,512,300 | 274,299 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $36,798,748 | 251,495 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $37,593,462 | 241,061 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,180,359 | 231,888 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $38,674,531 | 237,369 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $37,379,906 | 191,319 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $32,463,566 | 187,261 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $14,446,134 | 85,374 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $16,607,106 | 84,142 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $15,272,834 | 87,785 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $15,479,268 | 89,886 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,009,031 | 96,185 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $13,913,750 | 94,942 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,556,523 | 91,419 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $14,926,240 | 86,836 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $15,865,322 | 84,126 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $18,339,342 | 75,152 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $14,776,771 | 76,114 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $13,716,468 | 73,602 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,206,119 | 71,159 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,406,094 | 68,919 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $10,431,704 | 63,081 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $8,371,088 | 61,085 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $6,930,999 | 58,892 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||